SfN Journals, Elsevier Launch New Educational Series
WASHINGTON – SfN Journals and Elsevier announced a new educational series for early career neuroscientists as they pursue publication in research journals. This one-year pilot program will begin with an interactive panel discussion on November 14 at SfN’s annual meeting, Neuroscience 2023, followed by three webinars in 2024.
The joint initiative will provide early career neuroscientists direct interaction with journal publishers, editors, authors, and other experts on different issues relating to scientific publishing. The series intends to address specific needs and questions of early career researchers as they plan their publishing futures, increase engagement between major publishers and the author community, and provide greater clarity between early career researchers and publishers on their respective needs to support high-quality contributions to neuroscience journals. While SfN and Elsevier are the initial co-organizers, engagement of other publishers in this initiative is welcomed.
“SfN is delighted to join Elsevier in this new collaboration to support early career scientists as they look to optimize the visibility and impact of their research,” said Jasna Markovac, incoming chair of the SfN Scientific Publications Committee, which oversees SfN’s JNeurosci and eNeuro journals.
“We very much look forward to this expanded partnership with the Society for Neuroscience to provide impactful support to researchers in the neuroscience community, particularly those in the early stages of their careers,” said Louise Curtis, senior vice president, Elsevier. “We also sincerely appreciate the collaboration of contributors who offer their time and expertise to what promises to be a dynamic and insightful workshop series.”
The educational series will launch with an interactive panel discussion, “Publishing and Researcher Evaluation,” on November 14 at Neuroscience 2023 in Washington, D.C. Led by co-moderators Jasna Markovac and Gail Rodney, senior publisher, Elsevier, this interactive panel discussion will cover common ways researchers and articles are evaluated in hiring, promotion, and funding decisions, including impact factor, h-index, and other bibliometrics, as well as some emerging alternatives. As the largest gathering of researchers studying the brain and nervous system, Neuroscience 2023 will convene over 25,000 attendees; nearly half will be early career scientists at the student, postdoctoral fellow, or junior faculty stages.
Following the panel discussion at Neuroscience 2023, SfN Journals and Elsevier will co-host three, 60-minute quarterly webinars in 2024 on specific topics in publishing. All webinars will be recorded and placed on Neuronline, SfN’s online home for learning and discussion, so that these resources can be made available and promoted to the broader neuroscience community.
For more information about this initiative, please contact firstname.lastname@example.org.
The Society for Neuroscience (SfN) is the world’s largest organization of scientists and physicians devoted to understanding the brain and the nervous system. Founded in 1969, SfN now has nearly 35,000 members in more than 95 countries. SfN’s mission is to advance scientific exchange, support the neuroscience community, educate and engage the public, and advocate for the field. Year-round programming includes the publishing of two highly regarded scientific journals, JNeurosci and eNeuro. SfN’s annual meeting regularly attracts more than 25,000 attendees, representing over 70 countries, 450 exhibiting companies, and nearly 150 journalists.
As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems.
In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, academic leaders, funders, R&D-intensive corporations, doctors, and nurses.
Elsevier employs 9,000 people worldwide, including over 2,500 technologists. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, and health education. Researchers and healthcare professionals rely on over 2,800 journals, including The Lancet and Cell; 46,000+ eBook titles; and iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.
Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.